Dachaigh › Lymphoma Cealla B Mòr Sgaoilte › Nebraska
Sgrùdaidhean clionaigeach Lymphoma Cealla B Mòr Sgaoilte ann an Nebraska
Tha 9 sgrùdaidhean airson Lymphoma Cealla B Mòr Sgaoilte a’ lorg phàirtichean aig làraichean ann an Nebraska.
Bailtean ann an Nebraska
Teacsa sgrùdaidh oifigeil (Beurla)
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
- Nebraska Medicine-Bellevue, Bellevue
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06649812A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
- Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0188), Grand Island
- Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0177), Omaha
A’ fastadhÌre 2/3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT05139017A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
- NHO Revive Research Institute, LLC ( Site 0121), Lincoln
- University Of Nebraska Medical Center ( Site 0110), Omaha
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06890884A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- The University of Nebraska Medical Center, Omaha
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07195916Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
- Nebraska Cancer Specialists, Omaha
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT06806033Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- University of Nebraska Medical Center, Omaha
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT05826535A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- University of Nebraska Medical Center (UNMC), Omaha
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT07188558The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
A’ fastadhÌre 1/2
Aoisean 12 gu 95 · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT04329728DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Oncology Hematology West, PC dba Nebraska Cancer Specialists, Omaha
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Gibl 2023 · NCT04920617Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.